Two Cases of Hepatocellular Carcinoma Occurring Immediately after Direct-acting Antiviral Agents against Hepatitis C Virus

Intern Med. 2019 Jan 15;58(2):225-231. doi: 10.2169/internalmedicine.0712-17. Epub 2018 Aug 24.

Abstract

We experienced two cases of hepatocellular carcinoma (HCC) occurring immediately after treatment with direct-acting antiviral agents (DAAs). Case 1 was a 75-year-old woman in whom HCC was detected immediately after completion of DAA treatment. Case 2 was a 75-year-old woman who had a hypovascular nodule in liver. The hypovascular nodule became hypervascular without enlargement of the nodule size immediately after DAA treatment completion. Although the association between DAA treatment and hepatocarcinogenesis is unknown, sufficient surveillance after achieving a sustained viral response is required, as a large number of patients at a high risk of hepatocarcinogenesis are treated with DAAs.

Keywords: direct-acting antiviral agents; hepatitis C virus; hepatocellular carcinoma; sustained virological response.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Carcinoma, Hepatocellular / chemically induced*
  • Carcinoma, Hepatocellular / diagnostic imaging
  • Cell Transformation, Neoplastic / drug effects
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / virology
  • Humans
  • Liver Neoplasms / chemically induced*
  • Liver Neoplasms / diagnostic imaging
  • Sustained Virologic Response
  • Tomography, X-Ray Computed
  • Ultrasonography

Substances

  • Antiviral Agents